CSDIX
Price
$19.10
Change
+$0.06 (+0.32%)
Updated
Jun 2 closing price
Net Assets
9.52B
PFRSX
Price
$30.50
Change
+$0.05 (+0.16%)
Updated
Jun 2 closing price
Net Assets
6.73B
Interact to see
Advertisement

CSDIX vs PFRSX

Header iconCSDIX vs PFRSX Comparison
Open Charts CSDIX vs PFRSXBanner chart's image
CSDIX vs PFRSX Comparison Chart in %
View a ticker or compare two or three
VS
CSDIX vs. PFRSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSDIX is a Hold and PFRSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSDIX has more cash in the bank: 9.52B vs. PFRSX (6.73B). CSDIX pays higher dividends than PFRSX: CSDIX (2.80) vs PFRSX (2.38). CSDIX was incepted earlier than PFRSX: CSDIX (28 years) vs PFRSX (10 years). CSDIX (0.85) and PFRSX (0.81) have similar cost to investors . CSDIX is a more actively managed with annual turnover of: 27.00 vs. PFRSX (18.50). PFRSX has a lower initial minimum investment than CSDIX: PFRSX (0) vs CSDIX (100000). CSDIX annual gain was more profitable for investors over the last year : 10.44 vs. PFRSX (8.68). CSDIX (11.48) and PFRSX (11.14) have equivalent 5 years return.
CSDIXPFRSXCSDIX / PFRSX
Total Expense Ratio0.850.81105%
Annual Report Gross Expense Ratio0.850.81105%
Fund Existence28 years10 years-
Gain YTD10.42910.440100%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.52B6.73B141%
Annual Yield % from dividends2.802.38117%
Returns for 1 year10.448.68120%
Returns for 3 years35.1527.77127%
Returns for 5 years11.4811.14103%
Returns for 10 years66.18N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRMN54.651.00
+1.86%
Karman Holdings Inc
CHMG69.430.73
+1.06%
Chemung Financial Corp
META597.63-2.84
-0.47%
Meta Platforms
RNXT0.91-0.01
-0.76%
RenovoRx
AGIO26.50-1.50
-5.36%
Agios Pharmaceuticals